SILVESTRINI BRUNO has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1976. It filed its patents most often in Italy, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and biotechnology are GENETIC IMMUNITY LLC, ADVANCED BIOADJUVANTS LLC and FORTE SUBSIDIARY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Biotechnology | |
#4 | Foods and drinks | |
#5 | Consumer goods | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices | |
#4 | Microorganisms | |
#5 | Dairy products | |
#6 | Footwear features | |
#7 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Silvestrini Bruno | 14 |
#2 | Bonanomi Michele | 3 |
#3 | Cioli Valerio | 2 |
#4 | Buratto Alberto | 2 |
#5 | Buratto Camillo | 2 |
#6 | Kirschner Gunter | 1 |
#7 | Innocenti Matteo | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017141282A1 | A dosage form comprising a calcium salt, collagen and a drug and related use in a method of controlled release endowed with a regulatory mechanism of drug release inside the composition | |
EP2222316A2 | Use of partly hydrolyzed fish gelatin for the preparation of topically administered pharmaceutical compositions | |
EP2035033A1 | Pharmaceutical composition for the sublingual administration of vaccines, method for the preparation of the same and uses thereof | |
EP1631253A1 | Sublingual administration of non-steroidal anti-inflammatory pharmacological substances | |
EP0980654A2 | Combined pronation and supination control plantar insert for shoes | |
US4749684A | Method for increasing hair growth | |
US4154832A | Novel treatment for acute organic cerebral syndromes (strokes) |